Park JO - Search Results

1

Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.

Lee EM, Park JO, Kim D, Kim JY, Oh KH, Park CG, Oh BH, Kim S, Ahn C. Lee EM, et al. Among authors: park jo, park cg. Xenotransplantation. 2006 Jul;13(4):328-36. doi: 10.1111/j.1399-3089.2006.00311.x. Xenotransplantation. 2006. PMID: 16768726

2

Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells.

Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: park ys, park jo, park k. Biochem Biophys Res Commun. 2005 Aug 26;334(2):313-8. doi: 10.1016/j.bbrc.2005.06.093. Biochem Biophys Res Commun. 2005. PMID: 16005433

3

Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

Yun J, Kim KM, Kim ST, Kim JH, Kim JA, Kong JH, Lee SH, Won YW, Sun JM, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. Yun J, et al. Among authors: park ys, park sh, park jo. Cancer Res Treat. 2010 Jun;42(2):101-6. doi: 10.4143/crt.2010.42.2.101. Epub 2010 Jun 30. Cancer Res Treat. 2010. PMID: 20622964 Free PMC article.

4

Interferon-alpha resistance can be reversed by inhibition of IFN-alpha-induced COX-2 expression potentially via STAT1 activation in A549 cells.

Lee J, Jung HH, Im YH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: park ys, park jo, park k. Oncol Rep. 2006 Jun;15(6):1541-9. Oncol Rep. 2006. PMID: 16685393

5

Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancer.

Lee SH, Ahn YC, Kim HJ, Lim DH, Lee SI, Nam E, Park SH, Park J, Lee KE, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, Park K. Lee SH, et al. Among authors: park sh, park jo, park k, park j. Jpn J Clin Oncol. 2003 Dec;33(12):620-5. doi: 10.1093/jjco/hyg115. Jpn J Clin Oncol. 2003. PMID: 14769839 Clinical Trial.

6

Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.

Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK. Lee J, et al. Among authors: park c, park jo. J Natl Cancer Inst. 2011 Apr 20;103(8):674-88. doi: 10.1093/jnci/djr070. Epub 2011 Mar 11. J Natl Cancer Inst. 2011. PMID: 21398618

7

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, Kang WK, Park JO. Lee J, et al. Among authors: park ys, park sh, park jo. Oncol Rep. 2011 Jun;25(6):1517-24. doi: 10.3892/or.2011.1219. Epub 2011 Mar 18. Oncol Rep. 2011. PMID: 21424128

8

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, Noh JH, Heo JS, Kim YI, Park CK, Park K. Kim S, et al. Among authors: park ys, park ck, park ch, park sh, park jo, park k. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. doi: 10.1016/j.ijrobp.2005.05.005. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099596

9

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group. Kim TW, et al. Among authors: park jo. Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590. Acta Oncol. 2005. PMID: 16076694 Clinical Trial.

10

Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.

Kim WS, Son HJ, Park JO, Song SY, Park C. Kim WS, et al. Among authors: park c, park jo. Int J Mol Med. 2003 Dec;12(6):827-30. Int J Mol Med. 2003. PMID: 14612952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

907 results

Search Page

Filters